Journal: Molecular Pain
Article Title: Activation of mammalian target of rapamycin mediates rat pain-related responses induced by BmK I, a sodium channel-specific modulator
doi: 10.1186/1744-8069-9-50
Figure Lengend Snippet: 200 μM rapamycin inhibited the activation of spinal mTOR, 4E-BP1 and p70 S6K assessed by Western blot. (A) & (F) , representative western blots showing levels of p-mTOR, p-4E-BP, p-p70 S6K, total mTOR and β-actin in ipsi- (A) and contralateral (B) side of the spinal cord. (B - E) & (G - J) , histograms represent the mean levels with respect to each saline-treated group at 2 h after i.pl. BmK I injection. The data are presented as mean ± S.E.M. of three rats per group. N.s., ** p <0.01, *** p <0.001, compared with saline-treated group by One-way ANOVA, followed by Bonferroni's post hoc test.
Article Snippet: The membranes were incubated with the following primary antibodies which were diluted in PBS-T containing 5% nonfat milk for 5 h at room temperature: rabbit polyclonal antibody against p-mTOR (Ser2448, 1:1000; #2971; Cell Signaling Technology, MA [ ])/rabbit monoclonal antibody against mTOR (7C10, 1:1200; #2983; Cell Signaling Technology, MA)/rabbit polyclonal antibody against p-p70 S6K (Thr421/Ser424, 1:1500; sc-7984-R; Santa Cruz, CA [ ])/rabbit monoclonal antibody against p-4E-BP1 (Thr37/46, 1:1000; #2855; Cell Signaling Technology, MA)/rabbit polyclonal antibody against Actin (I-19, 1:1000; sc-1616; Santa Cruz, CA).
Techniques: Activation Assay, Western Blot, Injection